Summary
The unmet clinical needs in the management of bladder cancer (BCa) are the prevention of tumor onset/relapse/progression, and therapy of the aggressive bladder carcinoma in situ (Cis).EDIT will exploit the structural and mechanical properties of the bladder extracellular...
More information & hyperlinks
Web resources: | https://www.edit-h2020.eu/ |